Woodline Partners’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-143,980
| Closed | -$1.28M | – | 793 |
|
|
2023
Q1 | $1.28M | Sell |
143,980
-90,022
| -38% | -$799K | 0.02% | 458 |
|
|
2022
Q4 | $1.17M | Sell |
234,002
-2,388
| -1% | -$11.9K | 0.02% | 531 |
|
|
2022
Q3 | $1.37M | Buy |
236,390
+24,706
| +12% | +$143K | 0.02% | 506 |
|
|
2022
Q2 | $1.17M | Sell |
211,684
-38,316
| -15% | -$212K | 0.02% | 499 |
|
|
2022
Q1 | $2.88M | Hold |
250,000
| – | – | 0.05% | 329 |
|
|
2021
Q4 | $3.17M | Buy |
+250,000
| New | +$3.17M | 0.05% | 348 |
|